Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 29386 AL 29400

The prevalence of apathy in Lewy body dementia: A systematic review and meta-analysis

Yu JJ, Chin KS, Loveland PM, Churilov L, Loi SM, Yassi N, Watson R.

Alzheimers Dement. 2025 Jul;21(7):e70425. doi: 10.1002/alz.70425.

Detoxification and age-related neurodegenerative diseases: Correlation and therapeutic potential

Yan Y, Maisenbacher M, Huang C, Fan S.

Pharmacol Res. 2025 Aug;218:107849. doi: 10.1016/j.phrs.2025.107849. Epub 2025 Jul 2.

Neuroprotective effects of essential oils in animal models of Alzheimer's and Parkinson's disease: a systematic review

Macedo ADES, Ferreira TM, Krejcová LV, Rocha FAF, da Silva JKR, Pedrosa LRR, Gomes BD.

PeerJ. 2025 Jul 10;13:e19643. doi: 10.7717/peerj.19643. eCollection 2025.

Efficacy of repetitive transcranial magnetic stimulation in cognitive impairment of neurodegenerative diseases: a systematic review and meta-analysis

Zhang Y, Xu K, Wang Y, Shen Y, Liu Z, Zhang C, Zhou Y, Lv P, Bai Y, Wang S.

BMC Neurol. 2025 Jul 17;25(1):295. doi: 10.1186/s12883-025-04292-4.

Digital Therapeutics for Alzheimer's and Parkinson's Diseases: Current Trends and Future Perspectives

Jeong YJ, Lee HJ, Kim JS, Kim SJ, Jo U, Park JY, Jun SJ, Lee WS, Song M, Kim D, Cho G, Song JH, Hoe HS.

Med Res Rev. 2026 Jan;46(1):316-327. doi: 10.1002/med.70005. Epub 2025 Jul 31.

Next-generation CRISPR gene editing tools in the precision treatment of Alzheimer's and Parkinson's disease

Meshram HK, Gupta SK, Gupta A, Nagori K, Ajazuddin.

Ageing Res Rev. 2025 Sep;111:102851. doi: 10.1016/j.arr.2025.102851. Epub 2025 Aug 5.

Searching Heterocyclic Scaffolds Used to Treat Alzheimer's Disease: A Review

Kale MA, Faisal M.

Curr Drug Res Rev. 2025;17(2):266-281. doi: 10.2174/0125899775290026240612104933.

The link between oral health and neurodegeneration: a review of periodontitis in Alzheimer's and Parkinson's disease and dementia

Wagaskar P, Gaikwad S, Suryawanshi M, Patil A.

Inflammopharmacology. 2025 Sep;33(9):5023-5036. doi: 10.1007/s10787-025-01888-7. Epub 2025 Aug 12.

An Interdisciplinary Approach to Assistive Technology for Parkinson's Disease Dementia

Munzesheimer S, Siu TWT, Yacinthe D, Garcia-Casals M, Haq IU, Shpiner DS.

Clin Interv Aging. 2025 Aug 15;20:1253-1265. doi: 10.2147/CIA.S516786. eCollection 2025.

Converging pathologies in neurodegeneration: the mechanistic interplay between α-Synuclein and Tau in Alzheimer's and Parkinson's

Jeyabalan JB, Pandi A V, Veintramuthu S, Sivasamy R, Dhanasekaran M, Justin A.

Neurol Sci. 2025 Oct;46(10):4779-4789. doi: 10.1007/s10072-025-08421-2. Epub 2025 Aug 26.

Glycogen synthase kinase-3: the master switch driving neurodegeneration in Alzheimer's disease and Parkinson's disease

Liu Y, Zhang J, Tang L, Yang J, Hao L, Lou F, Su J.

Arch Toxicol. 2025 Dec;99(12):4709-4735. doi: 10.1007/s00204-025-04174-1. Epub 2025 Aug 28.

The Influence of Insulin Resistance and Type 2 Diabetes on Cognitive Decline and Dementia in Parkinson's Disease: A Systematic Review

Zeidan O, Jaragh N, Tama M, Alkhalifa M, Alqayem M, Butler AE.

Int J Mol Sci. 2025 Aug 21;26(16):8078. doi: 10.3390/ijms26168078.

Retinal imaging and artificial intelligence: A systematic review and meta-analysis of diagnostic techniques for neurodegenerative diseases

Ganji Z, Nikparast F, Shoeibi N, Shoeibi A, Zare H, Sharak NA.

Photodiagnosis Photodyn Ther. 2025 Oct;55:104788. doi: 10.1016/j.pdpdt.2025.104788. Epub 2025 Aug 29.

Language dysfunction as a primary feature of cognitive decline in neurological populations

Leavitt VM, Simani L, Haghighi AB, Koch M, König A, Rusz J.

J Neural Transm (Vienna). 2026 Mar;133(3):397-407. doi: 10.1007/s00702-025-03015-w. Epub 2025 Sep 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias